Brief: IMAC Holdings Says Submitted IND With FDA For Proposed Study To Evaluate Umbilical Cord-Derived Stem Cells Use For Treating Bradykinesia
15/05/2020 21:36
May 15 (Reuters) - IMAC Holdings Inc IMAC.O :
* IMAC HOLDINGS - ON MAY 12, SUBMITTED IND WITH FDA FOR CO'S
PROPOSED STUDY TO EVALUATE UMBILICAL CORD-DERIVED STEM CELLS USE
FOR TREATING BRADYKINESIA
Source text: (https://bit.ly/2yb3OK4)
Further company coverage: IMAC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Imac Holdings
See all newsBrief: Nasdaq To Suspend Imac Holdings Stock Trading On March 26, 2025
Imac Holdings Inc Reports Results For The Quarter Ended September 30: Earnings Summary
Brief: Imac Holdings Inc - Regains Compliance With Nasdaq Audit Committee Rule
Imac Holdings Inc Reports Results For The Quarter Ended June 30: Earnings Summary
Brief: IMAC Holdings Enters Agreement To Issue 4,676 Shares Of Series G Preferred Stock